GPT and Alzheimer disease: Alanine aminotransferase and AST are used in general clinical practice to measure liver injury5,6 and are factors associated with cardiovascular and metabolic diseases,7,8 known risk factors of AD and cognitive decline.9,10 Given this fact, it is conceivable that aminotransferases are surrogate biomarkers of liver metabolic functioning.